biomea fusion
Joy Valderrama has extensive experience as an Executive Assistant across various prominent companies. Currently serving as Executive Assistant to the Chief Executive Officer and Executive Team at biomea fusion since September 2020, Joy previously held positions as Executive Assistant to the Chief Commercial Officer at Rigel Pharmaceuticals Inc. and as Executive Assistant to the Chief Risk Modeling Officer at RMS. Joy's career also includes supporting the CEO at Cutera, Inc., where interactions with investors were a key responsibility, and providing assistance to senior executives at Synarc, managing complex schedules and facilitating communications with internal and external stakeholders.
This person is not in any teams
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.